NCI News
Part 2 of the 2021 Annual Report to the Nation on the Status of Cancer, finds that the patient economic burden associated with cancer care in the United States in 2019 was $21.09 billion. This includes patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.
Part 2 of the 2021 Annual Report to the Nation on the Status of Cancer, finds that the patient economic burden associated with cancer care in the United States in 2019 was $21.09 billion. This includes patient out-of-pocket costs of $16.22 billion and patient time costs of $4.87 billion.
A large surveillance study led by NCI researchers suggests that the global COVID-19 pandemic has caused more deaths in the United States among Black, American Indian/Alaska Native, and Latino individuals than among white or Asian individuals.
A large surveillance study led by NCI researchers suggests that the global COVID-19 pandemic has caused more deaths in the United States among Black, American Indian/Alaska Native, and Latino individuals than among white or Asian individuals.
NIH study illuminates origins of lung cancer in never smokers
9/06/2021
NCI scientists and their international collaborators have found that the majority of lung cancers in never smokers arise when mutations caused by natural processes in the body accumulate. They also identified three subtypes of lung cancer these individuals.
NIH study illuminates origins of lung cancer in never smokers
9/06/2021
NCI scientists and their international collaborators have found that the majority of lung cancers in never smokers arise when mutations caused by natural processes in the body accumulate. They also identified three subtypes of lung cancer these individuals.
In a common genetic disorder, blood test reveals when benign tumors turn cancerous
8/31/2021
NCI scientists have developed a blood test that could one day offer a highly sensitive and inexpensive approach to detect cancer early in people with NF1. The blood test could also help doctors monitor how well patients are responding to treatment for their cancer.
In a common genetic disorder, blood test reveals when benign tumors turn cancerous
8/31/2021
NCI scientists have developed a blood test that could one day offer a highly sensitive and inexpensive approach to detect cancer early in people with NF1. The blood test could also help doctors monitor how well patients are responding to treatment for their cancer.
The 2021 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline in the United States for all cancer sites combined. The rapid drop in lung cancer and melanoma deaths led to the overall decline.
The 2021 Annual Report to the Nation on the Status of Cancer finds overall cancer death rates continue to decline in the United States for all cancer sites combined. The rapid drop in lung cancer and melanoma deaths led to the overall decline.